Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Gross Profit (2019 - 2025)

Historic Gross Profit for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $16.1 million.

  • Pulmonx's Gross Profit rose 682.82% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.2 million, marking a year-over-year increase of 1424.39%. This contributed to the annual value of $62.0 million for FY2024, which is 2216.46% up from last year.
  • As of Q3 2025, Pulmonx's Gross Profit stood at $16.1 million, which was up 682.82% from $17.2 million recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Gross Profit registered a high of $17.6 million during Q4 2024, and its lowest value of $6.6 million during Q1 2021.
  • Moreover, its 5-year median value for Gross Profit was $12.7 million (2023), whereas its average is $12.5 million.
  • In the last 5 years, Pulmonx's Gross Profit surged by 79219.37% in 2021 and then soared by 424.07% in 2022.
  • Pulmonx's Gross Profit (Quarter) stood at $10.3 million in 2021, then grew by 9.1% to $11.2 million in 2022, then grew by 28.76% to $14.4 million in 2023, then increased by 22.15% to $17.6 million in 2024, then fell by 8.74% to $16.1 million in 2025.
  • Its last three reported values are $16.1 million in Q3 2025, $17.2 million for Q2 2025, and $16.3 million during Q1 2025.